Warren Buffet shocks Wall Street with Biogen gamble

Biogen is trying to resurrect two failed trials of its Alzheimer’s drug aducanumab – and superstar investor Warren Buffet thinks the volatile stock is worth gambling on as the company prepa

COVID-19 could disrupt supplies of cheap generics, analysts ...

An extended COVID-19 coronavirus outbreak could impact on supplies of generic drugs that many health systems rely on to keep costs as low as possible, according to a new report from ratings

First Rituxan biosimilar Truxima set to make its debut in US

Federal opioid trial averted by last-ditch settlement

Is the US opioid litigation nearing an end game?